Separation used for purification of recombinant proteins

被引:30
作者
Dyr, JE
Suttnar, J
机构
[1] Department of Biochemistry, Inst. Hematol. and Blood Transfus., 128 20 Prague 2
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1997年 / 699卷 / 1-2期
关键词
reviews; recombinant proteins; proteins;
D O I
10.1016/S0378-4347(97)00201-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The purification of molecules from recombinant;cells may lie strongly influenced by the molecular biology of gene isolation and expression. At the beginning of the process there may be a demand for information on the minute amounts of proteins and thus for ever increasingly sensitive techniques. Purification of recombinant proteins can differ from. conventional purifications in several ways, depending on the solubility of the protein, occurrence in inclusion bodies, creation of fusion proteins with tags that enable simpler purification. Sometimes a (re)naturation step is required to get a bioactive protein. On the other hand, the techniques used in separation are essentially the same as;for purification from the natural source and environment. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:383 / 401
页数:19
相关论文
共 102 条
[61]  
KLEMAN G L, 1992, Current Opinion in Biotechnology, V3, P93, DOI 10.1016/0958-1669(92)90134-5
[62]   RECOMBINANT PROTEINS FOR MEDICAL USE - THE ATTRACTIONS AND CHALLENGES [J].
KOTHS, K .
CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) :681-687
[63]   Improved method for pro-urokinase refolding with inclusion body from recombinant Escherichia coli [J].
Kubo, M ;
Nishi, A .
JOURNAL OF FERMENTATION AND BIOENGINEERING, 1995, 80 (06) :622-624
[64]   RATIONAL DESIGN OF PURIFICATION PROCESSES FOR RECOMBINANT PROTEINS [J].
LESER, EW ;
ASENJO, JA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 584 (01) :43-57
[65]   PRODUCTION AND SIMPLE PURIFICATION OF A PROTEIN ENCODED BY PART OF THE GAG GENE OF HIV-1 IN THE ESCHERICHIA-COLI HB101F(+) EXPRESSION SYSTEM INDUCIBLE BY LACTOSE AND ISOPROPYL-BETA-D-THIOGALACTOPYRANOSIDE [J].
LISKA, V ;
DYR, JE ;
SUTTNAR, J ;
HIRSCH, I ;
VONKA, V .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 656 (01) :127-133
[66]   PRODUCTION OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-TYPE-I IN ESCHERICHIA-COLI - OPTIMIZATION OF THE REFOLDING YIELDS BY A MICROTITER DILUTION ASSAY [J].
MERLI, S ;
CORTI, A ;
CASSANI, G .
ANALYTICAL BIOCHEMISTRY, 1995, 230 (01) :85-91
[67]   CO-OVEREXPRESSION OF PRLF INCREASES CELL VIABILITY AND ENZYME YIELDS IN RECOMBINANT ESCHERICHIA-COLI EXPRESSING BACILLUS-STEAROTHERMOPHILUS ALPHA-AMYLASE [J].
MINAS, W ;
BAILEY, JE .
BIOTECHNOLOGY PROGRESS, 1995, 11 (04) :403-411
[68]   Upstream strategies to minimize proteolytic degradation upon recombinant production in Escherichia coli [J].
Murby, M ;
Uhlen, M ;
Stahl, S .
PROTEIN EXPRESSION AND PURIFICATION, 1996, 7 (02) :129-136
[69]  
NEWCOMB R, 1989, LC GC EUR, V2, P28
[70]   AN IMPROVED METHOD FOR LARGE-SCALE PURIFICATION OF RECOMBINANT HUMAN GLUCAGON [J].
OKAMOTO, H ;
IWAMOTO, H ;
TSUZUKI, H ;
TERAOKA, H ;
YOSHIDA, N .
JOURNAL OF PROTEIN CHEMISTRY, 1995, 14 (07) :521-526